GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells. (2023)

First Author: Hansen MS
Attributed to:  Centre for Musculoskeletal Ageing Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ejendo/lvac004

PubMed Identifier: 36747334

Publication URI: http://europepmc.org/abstract/MED/36747334

Type: Journal Article/Review

Volume: 188

Parent Publication: European journal of endocrinology

Issue: 1

ISSN: 0804-4643